Spanish validation of the Brief Assessment in Cognition in Schizophrenia (BACS) in patients with schizophrenia and healthy controls

European Psychiatry

Volumn 26, Issue 2, 2011, Pages 69-73

  Segarra, N ^a,b,d   Bernardo, M ^a,b,c,d   Gutierrez, F ^a,b   Justicia, A ^a,c   Fernadez Egea, E ^a,b,c   Allas, M ^e   Safont, G ^f   Contreras, F ^e   Gascon, J ^f   Soler Insa, P A ^f   Menchon, J M ^e   Junque, C ^d   Keefe, R S E ^g  

^a HOSPITAL CLÍNIC   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

^e Universitary de Bellvitge   (Spain)

^f HOSPITAL MÚTUA DE TERRASSA   (Spain)

^g DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Brief assessment; Cognition; Schizophrenia; Spanish; Validation

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; CLOZAPINE; OLANZAPINE; RISPERIDONE; ZIPRASIDONE;

ADULT; AGED; ARTICLE; BRIEF ASSESSMENT IN COGNITION IN SCHIZOPHRENIA; COGNITION; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOLOGIC TEST; PSYCHOMETRY; SCHIZOPHRENIA; SPAIN; VALIDATION STUDY;

ADULT; CASE-CONTROL STUDIES; CHRONIC DISEASE; COGNITION DISORDERS; CROSS-CULTURAL COMPARISON; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHOMETRICS; PSYCHOTIC DISORDERS; REPRODUCIBILITY OF RESULTS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SPAIN; TRANSLATING; YOUNG ADULT;

EID: 79951577583     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2009.11.001     Document Type: Article

References (29)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, Text Revision (DSM-IV TR), Fourth Edition. Washintong, DC: 2000.
2. Anselmetti S., Poletti S., Ermoli E., Bechi M., Cappa S., Venneri A., et al. The Brief Assessment of Cognition in Schizophrenia. Normative data for the Italian population 1. Neurol Sci 2008, 29(2):85-92.
3. Antonova E., Sharma T., Morris R., Kumari V. The relationship between brain structure and neurocognition in schizophrenia: a selective review. Schizophr Res 2004, 70(2-3):117-145.
4. Army Individual Test Battery. Manual of Directions and Scoring. Washington, DC: War Department, Adjutant General's Office; 1944.
5. Borkowski J.G., Benton A.L., Spreen O. Word fluency and brain damage. Neuropsychologia 1967, 5:135-140.
6. Bralet M.C., Falissard B., Neveu X., Lucas-Ross M., Eskenazi A.M., Keefe R.S. Validation of the French version of the BACS (the brief assessment of cognition in schizophrenia) among 50 French schizophrenic patients. Eur Psychiatry 2007, 22(6):365-370.
7. Cockrell J.R., Folstein M.F. Mini-Mental State Examination (MMSE). Psychopharmacol Bull 1988, 24(4):689-692.
8. Dickinson D., Ragland J.D., Calkins M.E., Gold J.M., Gur R.C. A comparison of cognitive structure in schizophrenia patients and healthy controls using confirmatory factor analysis. Schizophr Res 2006, 85(1-3):20-29.
9. Dickinson D., Ragland J.D., Gold J.M., Gur R.C. General and specific cognitive deficits in schizophrenia: Goliath defeats David?. Biol Psychiatry 2008, 64(9):823-827.
10. Genderson M.R., Dickinson D., az-Asper C.M., Egan M.F., Weinberger D.R., Goldberg T.E. Factor analysis of neurocognitive tests in a large sample of schizophrenic probands, their siblings, and healthy controls. Schizophr Res 2007, 94(1-3):231-239.
11. Gold J.M., Queern C., Iannone V.N., Buchanan R.W. Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia I: sensitivity, reliability, and validity. Am J Psychiatry 1999, 156(12):1944-1950.
12. Goldberg T.E., Egan M.F., Gscheidle T., Coppola R., Weickert T., Kolachana B.S., et al. Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. Arch Gen Psychiatry 2003, 60(9):889-896.
13. Green M.F., Nuechterlein K.H., Gold J.M., Barch D.M., Cohen J., Essock S., et al. Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria 25. Biol Psychiatry 2004, 56(5):301-307.
14. Heaton R.K., Chelune G.J., Talley J.L., Kay G.G., Curtiss G. Wisconsin Card Sorting Test (WCST) Manual-Revised and Expanded 1993, Psychological Assessment Resources, Odessa, FL.
15. Kaneda Y., Sumiyoshi T., Keefe R., Ishimoto Y., Numata S., Ohmori T. Brief assessment of cognition in schizophrenia: validation of the Japanese version. Psychiatry Clin Neurosci 2007, 61(6):602-609.
16. Keefe R.S. Cognitive deficits in patients with schizophrenia: effects and treatment 1. J Clin Psychiatry 2007, 68(Suppl 14):8-13.
17. Keefe R.S., Bilder R.M., Harvey P.D., Davis S.M., Palmer B.W., Gold J.M., et al. Baseline neurocognitive deficits in the CATIE schizophrenia trial 16. Neuropsychopharmacology 2006, 31(9):2033-2046.
18. Keefe R.S., Goldberg T.E., Harvey P.D., Gold J.M., Poe M.P., Coughenour L. The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr Res 2004, 68(2-3):283-297.
19. Keefe R.S., Harvey P.D., Goldberg T.E., Gold J.M., Walker T.M., Kennel C., et al. Norms and standardization of the Brief Assessment of Cognition in Schizophrenia (BACS). Schizophr Res 2008, 102(1-3):108-115.
20. Keefe R.S., Poe M., Walker T.M., Harvey P.D. The relationship of the Brief Assessment of Cognition in Schizophrenia (BACS) to functional capacity and real-world functional outcome. J Clin Exp Neuropsychol 2006, 28(2):260-269.
21. Kiernan R.J., Mueller J., Langston J.W., Van D.C. The Neurobehavioral Cognitive Status Examination: a brief but quantitative approach to cognitive assessment. Ann Intern Med 1987, 107(4):481-485.
22. Lezak, et al. Neuropsychological Assessment 2004, Oxford University Press, New York. ed 4.
23. McGurk S.R., Mueser K.T. Cognitive functioning, symptoms, and work in supported employment: a review and heuristic model. Schizophr Res 2004, 70(2-3):147-173.
24. Nuechterlein K.H., Barch D.M., Gold J.M., Goldberg T.E., Green M.F., Heaton R.K. Identification of separable cognitive factors in schizophrenia 44. Schizophr Res 2004, 72(1):29-39.
25. Peralta V., Cuesta M.J. Psychometric properties of the positive and negative syndrome scale (PANSS) in schizophrenia. Psychiatry Res 1994, 53(1):31-40.
26. Pino O., Guilera G., Gomez J., Rojo J.E., Vellejo J., Purdon S.E. A brief scale to assess cognitive impairment in psychiatric patients. Psicothema 2006, 18(3):447-452.
27. Pino O., Guilera G., Rojo J.E., Gomez-Benito J., Bernardo M., Crespo-Facorro B., et al. Spanish version of the Screen for Cognitive Impairment in Psychiatry (SCIP-S): psychometric properties of a brief scale for cognitive evaluation in schizophrenia 1. Schizophr Res 2008, 99(1-3):139-148. Feb.
28. Rojo E., Pino O., Guilera G., Gomez-Benito J., Purdon S.E., Crespo-Facorro B., et al. Neurocognitive diagnosis and cut-off scores of the Screen for Cognitive Impairment in Psychiatry (SCIP-S. Schizophrenia research 2010 Feb, 116(2-3):243-251.
29. Wechsler D. Wechsler Adults Intelligence Scale 3, WAIS-III manual. Spanish version 1999, TEA Ediciones, Madrid.